Align Technology (MEX:ALGN) 3-Year Share Buyback Ratio : 2.10% (As of Mar. 2025)

View and export this data going back to 2018. Start your Free Trial

What is Align Technology 3-Year Share Buyback Ratio?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. A positive ratio may indicate share buybacks over the period, while a zero or negative ratio may reflect no repurchases or potential share issuance. Align Technology's current 3-Year Share Buyback Ratio was 2.10%.

The historical rank and industry rank for Align Technology's 3-Year Share Buyback Ratio or its related term are showing as below:

MEX:ALGN' s 3-Year Share Buyback Ratio Range Over the Past 10 Years
Min: -8.4 Med: -1.8 Max: 2.1
Current: 2.1

During the past 13 years, Align Technology's highest 3-Year Share Buyback Ratio was 2.10%. The lowest was -8.40%. And the median was -1.80%.

MEX:ALGN's 3-Year Share Buyback Ratio is ranked better than
96.25% of 640 companies
in the Medical Devices & Instruments industry
Industry Median: -3 vs MEX:ALGN: 2.10

Competitive Comparison of Align Technology's 3-Year Share Buyback Ratio

For the Medical Instruments & Supplies subindustry, Align Technology's 3-Year Share Buyback Ratio, along with its competitors' market caps and 3-Year Share Buyback Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Align Technology's 3-Year Share Buyback Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Align Technology's 3-Year Share Buyback Ratio distribution charts can be found below:

* The bar in red indicates where Align Technology's 3-Year Share Buyback Ratio falls into.

Save Embed

;

Save Embed

;

Align Technology 3-Year Share Buyback Ratio Calculation

This is the annualized percentage change in shares outstanding from three years ago to the current year. The annualized percentage change is calculated with expontential compound based on the latest four years of annual data on Shares Outstanding (EOP).

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

Align Technology (MEX:ALGN) 3-Year Share Buyback Ratio Explanation

A negative number means the company might be issuing new shares. A positive number indicates that the company is buying back shares.

Be Aware

Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.

Align Technology 3-Year Share Buyback Ratio Related Terms

Thank you for viewing the detailed overview of Align Technology's 3-Year Share Buyback Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Align Technology Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Align Technology Inc (MEX:ALGN) » Definitions » 3-Year Share Buyback Ratio

Comparable Companies

Traded in Other Exchanges

ALGN:USA 1ALGN:Italy 0HCK:UK AFW:Germany AFW:Germany A1LG34:Brazil ALGN:Austria

Address

410 North Scottsdale Road, Suite 1300, Tempe, AZ, USA, 85288

Website

https://www.aligntech.com

Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.